Hideki Nakayama

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Topics

Atomic Force Microscopy

Acute Lymphoblastic Leukemia

Diffuse Large B Cell Lymphoma

Top Venues

Translational pediatrics

International journal of hematology

Pediatrics international : official journal of the Japan Pediatric Society

This page only lists publications with an associated author ORCID identifier.

Publications

Hideki Nakayama
Three-year update outcomes of the first chimeric antigen receptor-T therapy for children and young adults with relapsed/refractory acute lymphoblastic leukemia. Translational pediatrics 13 (4) (2024)
Hideki Nakayama
Three-year update outcomes of the first chimeric antigen receptor-T therapy for children and young adults with relapsed/refractory acute lymphoblastic leukemia. Translational pediatrics 13 (4) (2024)
Hideki Nakayama, Chitose Ogawa, Masahiro Sekimizu, Hiroyuki Fujisaki, Yoshiyuki Kosaka, Hiroya Hashimoto, Akiko M Saito, Keizo Horibe
Correction to: A phase I study of inotuzumab ozogamicin as a single agent in pediatric patients in Japan with relapsed/refractory CD22-positive acute lymphoblastic leukemia (INO-Ped-ALL-1). International journal of hematology (2023)
Hideki Nakayama, Chitose Ogawa, Masahiro Sekimizu, Hiroyuki Fujisaki, Yoshiyuki Kosaka, Hiroya Hashimoto, Akiko M Saito, Keizo Horibe
A phase I study of inotuzumab ozogamicin as a single agent in pediatric patients in Japan with relapsed/refractory CD22-positive acute lymphoblastic leukemia (INO-Ped-ALL-1). International journal of hematology 116 (4) (2022)
Takashi Taga, Shiro Tanaka, Daisuke Hasegawa, Kiminori Terui, Tsutomu Toki, Shotaro Iwamoto, Hidefumi Hiramatsu, Takako Miyamura, Yoshiko Hashii, Hiroshi Mirotaki, Hideki Nakayama, Hiroyuki Takahashi, Akira Shimada, Tomohiko Taki, Etsuro Ito, Asahito Hama, Masafumi Ito, Katsuyoshi Koh, Daiichiro Hasegawa, Akiko M Saito, Souichi Adachi, Masanori Yoshida
Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndrome. Leukemia 35 (9) (2021)
Hiroshi Mirotaki, Shiro Tanaka, Takako Miyamura, Hideki Nakayama, Norio Shiba, Akira Shimada, Kiminori Terui, Yuki Yuza, Katsuyoshi Koh, Hiroaki Goto, Harumi Kakuda, Akiko Saito, Daisuke Hasegawa, Shotaro Iwamoto, Takashi Taga, Souichi Adachi, Masanori Yoshida
The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05R study. Pediatric blood & cancer 68 (1) (2020)
Hideki Nakayama, Daisuke Tomizawa, Shiro Tanaka, Shotaro Iwamoto, Akira Shimada, Akiko M Saito, Yuka Yamashita, Hiroshi Moritake, Kiminori Terui, Takashi Taga, Hidemasa Matsuo, Yoshiyuki Kosaka, Katsuyoshi Koh, Hajime Hosoi, Hidemitsu Kurosawa, Keiichi Isoyama, Keizo Horibe, Shuki Mizutani, Souichi Adachi
Fludarabine, cytarabine, granulocyte colony-stimulating factor and idarubicin for relapsed childhood acute myeloid leukemia. Pediatrics international : official journal of the Japan Pediatric Society 59 (10) (2018)